From: Genetic diversity of Plasmodium falciparum isolates in Nigeria. A review
 |  | Allelic Families |  | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
 |  | msp 1 | msp 2 |  | Multiplicity of Infection |  |  |  | |||
State | Place of Research | K1 | MAD20 | RO33 | FC27 | 3D7 | Sample size | MSP-1 | MSP-2Â | Type of population | References |
Kogi (North Central) | Idah | 70% | 20% | 40% | 40% | 20% | 80 | 1.05 | 2.13 | Riverine communities | [30] |
 | Ibaji | 40% | 10% | 20% | 30% | 20% |  | 1.30 | 2 |  |  |
Kwara (North Central) | Okelele | 56.25% | 41.67% | 47.92% | 43.75% | 27.08% | 50 | 1.7 | 1.8 | Rural community | [31] |
Nassarawa (North Central) | Lafia | NA | NA | NA | 60.5% | 39.5% | 93 | 2.31 | Â | Children in a similar microenvironment | [24] |
Nassarawa (North Central) | Lafia | NA | NA | NA | 45% | 55% | 116 | - | 1.3 | Children (1-8yrs) | [18] |
Nassarawa (North Central) | Lafia | NA | NA | NA | 59% | 38% | 180 | - | 2.2 | Asymptomatic group | [23] |
 |  | NA | NA | NA | 45% | 51% | 140 | - | 2.0 | Uncomplicated malaria group |  |
Niger (North Central) | Minna | 46% | 67% | 11% | 93% | 24% | 50 | 1.54 | 1.68 | Infants and children (6Â months-17Â years) | [15] |
Kaduna (North West) | Kaduna Metropolis | 20% | 60% | 0% | 25% | 62.5% | 30 | NA | Symptomatic | Â | [19] |
 |  | 0% | 20% | 0% | 8.33% | 4.17% | 12 | NA | Asymptomatic |  |  |
Lagos (South West) | Ajeromi-Ifelodun General Hospital, Lagos | 38% | 17% | 29% | 33% | 29% | 24 | 1.05 | 1.07 | Pregnant women | [34] |
 |  | 25% | 25% | 33% | 29% | 38% | 24 | 1.15 | 1.25 | Non-pregnant women |  |
Lagos (South West) | Lekki | 70% | 50% | 50% | 94% | 30% | 50 | 1.39 | 1.76 | Urban | [36] |
 | Ikorodu | 50% | 50% | 40% | 70% | 40% | 50 | 1.50 | 1.14 | Peri-urban area |  |
Lagos (South West) | Lagos State Teaching Hospital | 89.5% | 31.6% | 26.3% | NA | NA | 19 | 1.4 | Sickle cell anaemia patients (rural) | [26] | |
 |  | 72.2% | 33.3% | 5.6% | NA | NA | 18 | 1.5 | Sickle cell anaemia patients (urban) |  | |
Lagos (South West) | Lekki | NA | NA | NA | 31.0% | 19.7% | 195 | 1.54 | Patients from 3 different hospitals | [40] | |
Ogun (South West) | Ijebu | 20.6% | 22.5% | 30% | 23.2% | 21.1% | 20 | 1.1 | 1.2 | Ogun State General Hospital | [35] |
 | Yewa | 45.6% | 52.5% | 40% | 32.1% | 50% | 43 |  |  |  |  |
 | Egba | 22.1% | 17.5% | 20% | 32.1% | 15.8% | 25 |  |  |  |  |
 | Remo | 11.8% | 7.5% | 10% | 12.5% | 13.2% | 12 |  |  |  |  |
Oyo (South West) | Ibadan | 94% | 75% | 68% | NA | NA | 53 | - | - | AM | [41] |
 |  | 79% | 54% | 61% | NA | NA | 101 | - | - | UM |  |
 |  | 74% | 49% | 57% | NA | NA | 69 | - | - | SM |  |
Oyo (South west) | Idi-Ayunre | 2.6% | 3.3% | 7.3% | 3D7 + FC27 68.3% | 43.20% | 309 | 2.8 | Rural community | [28] | |
 | St. Mary Healthcare | 10.0% | 10.0% | 10.0% | 15.00% | 15.00% |  | 2.6 | Urban community |  | |
Oyo (South West) | Igbo-Ora | 26% | 17% | 57% | NA | NA | 143 | 1.7 | Individuals with submicroscopic infection | [33] | |
Oyo (South West) | Ibadan | NA | NA | NA | 35%* | 45%* | 75* | - | 2.8 | UM in two populations (A and B) | [25] |
 |  |  |  |  | 50% | 78% | 115 |  | 2.1 |  |  |
 |  | NA | NA | NA | 11%* | 28%* | 48* | - | 3.4 | CM in two populations (A and B) |  |
 |  |  |  |  | 52% | 56% | 55 |  | 1.3 |  |  |
 |  | NA | NA | NA | 40%* | 13%* | 41* | - | 1.9 | SMA in two populations (A and B) |  |
 |  |  |  |  | 57% | 58% | 55 |  |  | 1.5 |  |
Oyo (South West) | Ibadan | 79% | 32% | 38% | 85.1% | 85.1% | 47 | 2.5 | 4.9 | Children with failed chloroquine treatment | [32] |
Osun (South West) | Osogbo | NA | NA | NA | 62.3% | 68.1% | 101 | 1.6 | Ages 0–4 | [42] | |
 |  |  |  |  | 76.2% | 62% |  | 1.8 | Ages 4–8 |  | |
 |  |  |  |  | 73.0% | 27.3% |  | 1.3 | Ages 9–12 |  |